SHIFA BIOMEDICAL CORPORATION

Company Information
Address GREAT VALLEY CORPORATE CENTER
MALVERN, PA, 19355-1423


Information

DUNS: 192526221

# of Employees: 7


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Development of Oral Small Molecule PCSK9 Antagonist

    Amount: $682,343.00

    Project Summary Abstract The epidemic of cardiovascular disease CVD is a global phenomenon that remains the number one cause of death throughout the world killing nearly million people per ye ...

    SBIRPhase II2017Department of Health and Human Services National Institutes of Health
  2. Novel Modulators of LDL Metabolism

    Amount: $1,000,000.00

    DESCRIPTION provided by applicant Heart disease is the leading cause of death for both men and women in the US accounting for nearly of all annual deaths A high cholesterol level is well know ...

    SBIRPhase II2014Department of Health and Human Services National Institutes of Health
  3. Novel Modulators of HDL Metabolism

    Amount: $1,539,615.00

    Project Summary/Abstract Cardiovascular disease remains the leading cause of morbidity and mortality for both men and women, accounting for nearly 40% of annual deaths. High levels of LDL-C and low l ...

    SBIRPhase II2012Department of Health and Human Services
  4. A Novel Cassette System for the Assembly of VLP Vaccines

    Amount: $296,731.00

    DESCRIPTION (provided by applicant): Influenza and other infectious diseases are a major cause of death in the US and world-wide. Vaccination is the most cost-effective strategy to prevent these disea ...

    SBIRPhase I2012Department of Health and Human Services
  5. Novel Self-Limiting Prothrombinase Inhibitors

    Amount: $347,218.00

    Project Summary/Abstract Thrombosis is a primary cause of death in the US and developed world. Fatal or debilitating blood clots occur in the three major diseases of the western world: heart attacks, ...

    SBIRPhase I2012Department of Health and Human Services
  6. Structure-Based Search for Novel Antihypercholestrolemic Agent

    Amount: $1,336,680.00

    DESCRIPTION (provided by applicant): Heart disease is the leading cause of death for both men and women in the US, accounting for nearly 40% of all annual deaths. A high cholesterol level is well-know ...

    SBIRPhase II2010Department of Health and Human Services
  7. Structure-Based Design of Novel HNF4a Antagonists to Treat Metabolic Syndrome

    Amount: $290,230.00

    DESCRIPTION (provided by applicant): The long-term goal of this work is to develop novel drugs for the treatment of metabolic syndrome (MetS). MetS is an assemblage of associated clinical disorders re ...

    SBIRPhase I2010Department of Health and Human Services
  8. Novel Modulators of LDL Metabolism

    Amount: $258,591.00

    DESCRIPTION (provided by applicant): Heart disease is the leading cause of death for both men and women in the US, accounting for nearly 40% of all annual deaths. A high cholesterol level is a well-kn ...

    SBIRPhase I2009Department of Health and Human Services
  9. Novel Modulators of HDL Metabolism

    Amount: $270,518.00

    DESCRIPTION (provided by applicant): Cardiovascular disease remains the leading cause of morbidity and mortality for both men and women, accounting for nearly 40% of annual deaths. High levels of low- ...

    SBIRPhase I2009Department of Health and Human Services
  10. Search for Antithrombotic Compounds to Overcome Adverse Effects of Current Drugs

    Amount: $256,345.00

    DESCRIPTION (provided by applicant): Uncontrolled blood clotting or thrombosis is a primary cause of death in the US and developed world. Fatal or debilitating blood clots occur in the three major dis ...

    SBIRPhase I2008Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government